Healthcare Costs on the Rise: Maryland's Controversial Move to Tighten Regulations
In a move that has sparked intense debate, Maryland lawmakers are pushing forward a bill that could significantly impact the cost and accessibility of healthcare for residents. But here's where it gets controversial: while the intention is to curb consolidation in the healthcare sector, critics argue that it might actually lead to higher costs and fewer options for patients. Let’s dive into the details and explore why this issue is far from black and white.
Earlier this year, State Representative Bonnie Cullison (D–Aspen Hill) introduced House Bill (H.B.) 944, alongside its Senate counterpart, aiming to strengthen Maryland’s Certificate of Need (CON) laws. These laws, first introduced in the 1970s, require healthcare providers to obtain government approval before expanding or building new facilities. And this is the part most people miss: while CON laws were initially intended to control healthcare costs, they’ve often had the opposite effect, creating barriers to innovation and competition.
H.B. 944 would mandate that healthcare providers give a 90-day advance notice to the Maryland Health Care Commission (MHCC) for any 'material change transactions,' including mergers, acquisitions, and certain real estate deals. The commission could then approve the transaction or initiate a lengthy 'public interest review,' which might ultimately result in denial. But here’s the kicker: this process could stifle competition, favoring established providers over potential disrupters that might offer more affordable services.
To illustrate the impact of CON laws, consider the case of North Carolina. A yearslong legal battle between WakeMed Health and Hospitals and Duke University Hospital erupted over a Certificate of Need for a linear particle accelerator (LINAC) for cancer treatment. Despite WakeMed’s initial approval, Duke challenged the decision, leading to the CON being overturned. While the case was eventually dismissed after a settlement, the episode highlights how CON laws can delay life-saving treatments and foster anticompetitive behavior.
Here’s the shocking part: CON laws don’t just affect high-tech treatments like LINACs. They also restrict access to online vision tests, less invasive colonoscopies, mental health facilities, addiction treatment centers, Neonatal Intensive Care Units, specialized brain injury rehabilitation, freestanding birth centers, new MRI machines, and other essential medical services. In Maryland, which already has some of the strictest CON rules in the nation, these laws have delayed hospital openings and limited the size of ambulatory surgical centers, often forcing them to operate with fewer resources.
Despite these challenges, Maryland lawmakers are determined to strengthen CON laws. However, they face fierce opposition from stakeholders like the Maryland State Medical Society (MedChi) and the Maryland Chamber of Commerce. Gene Ransom, CEO of MedChi, warns that the bill could add unnecessary costs to healthcare facilities, ultimately burdening patients. Benjamin Lowentritt, a Maryland urologist, adds that the increased regulatory burden could deter private investors, stifling innovation and competition.
Here’s the million-dollar question: Are CON laws truly protecting patients, or are they inadvertently shielding incumbent providers from competition? While policymakers aim to prevent consolidation, critics argue that these regulations often have the opposite effect, making it harder for new, cost-effective providers to enter the market. The Maryland Chamber of Commerce echoes this concern, warning that the bill’s expansive regulatory review process could apply to a wide range of business transactions, further complicating an already complex environment.
As the bill moves forward, it’s unclear whether it will reach Governor Wes Moore’s desk. If it does, Maryland could become the most restrictive healthcare environment in the country, potentially raising costs for consumers and limiting access to care. But here’s where we want to hear from you: Do you think strengthening CON laws will protect patients, or will it stifle innovation and competition? Share your thoughts in the comments—this is a conversation that deserves your voice.
